Geode Capital Management, LLC Aerie Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $174,684 - $417,652	27,423 Added 3.28%	862,809 $13.1 Million
Q2 2022 Aug 12, 2022	BUY	$4.95 - $9.16 $354,687 - $656,350	71,654 Added 9.38%	835,386 $6.27 Million
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $420,636 - $730,893	-74,581 Reduced 8.9%	763,732 $6.95 Million
Q4 2021 Feb 11, 2022	BUY	$7.02 - $13.33 $1.3 Million - $2.46 Million	184,703 Added 28.26%	838,313 $5.88 Million
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $1.16 Million - $1.71 Million	-102,604 Reduced 13.57%	653,610 $7.45 Million
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $893,333 - $1.12 Million	58,927 Added 8.45%	756,214 $12.1 Million
Q1 2021 May 12, 2021	BUY	$13.12 - $20.9 $890,795 - $1.42 Million	67,896 Added 10.79%	697,287 $12.5 Million
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $184,971 - $293,886	20,282 Added 3.33%	629,391 $8.5 Million
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $27,854 - $38,506	-2,663 Reduced 0.44%	609,109 $7.17 Million
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $301,704 - $405,540	-25,142 Reduced 3.95%	611,772 $9.03 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $529,851 - $1.14 Million	44,751 Added 7.56%	636,914 $8.6 Million
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $681,688 - $965,597	38,470 Added 6.95%	592,163 $14.3 Million
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $370,353 - $563,276	20,117 Added 3.77%	553,693 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $1.71 Million - $2.85 Million	59,128 Added 12.46%	533,576 $15.8 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $1.4 Million - $1.9 Million	38,565 Added 8.85%	474,448 $22.5 Million
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $677,787 - $1.23 Million	20,539 Added 4.95%	435,883 $15.7 Million
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $852,076 - $1.12 Million	15,175 Added 3.79%	415,344 $25.6 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $2.94 Million - $4.33 Million	61,492 Added 18.16%	400,169 $27 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $848,425 - $1.01 Million	16,587 Added 5.15%	338,677 $18.4 Million
Q4 2017 Feb 13, 2018	BUY	$50.85 - $65.1 $653,880 - $837,120	12,859 Added 4.16%	322,090 $19.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $805,253 - $995,796	16,569 Added 5.66%	309,231 $15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	292,662	292,662 $15.4 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account